Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · DRS/A

Everfront Biotech Holding Co Ltd

SEC Filing

Filed Dec 6, 2024Accepted Dec 5, 2024, 6:50 PM ESTCIK 2001611Accession 0001493152-24-048932
Share

Company context

Everfront Holding is a holding company incorporated in the British Virgin Islands (“BVI”) that conducts its operations through its 99.96% owned subsidiary, Everfront Biotech Inc. (“Everfront Biotech”), which is incorporated and operates in Taiwan. Everfront Holding holds no other assets and conducts no operations of its own.

Recent company filings

  1. F-1/A filingDec 11, 2025
  2. F-1/A filingJun 23, 2025
  3. F-1 filingJan 3, 2025
  4. DRS/A filingSep 27, 2024
  5. DRS/A filingAug 22, 2024

As-filed source

Primary evidence